PKBO
Income statement / Annual
Last year (2023), Peak Bio, Inc.'s total revenue was $367,877.00,
a decrease of 39.46% from the previous year.
In 2023, Peak Bio, Inc.'s net income was -$1,259.26.
See Peak Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$367,877.00
|
$607,681.00
|
$528,309.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$107.10 |
$108.58 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$367,769.00 |
$607,572.00 |
$528,309.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
1 |
1 |
1 |
0 |
0 |
| Research and Development
Expenses |
$0.00
|
$3.92 M
|
$7.12 M
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$218.68
|
$8.53 M
|
$2.47 M
|
$332.09
|
$173.88
|
| Selling & Marketing
Expenses |
$9.06
|
$8.86
|
$18.19
|
$99.02
|
$16.94
|
| Selling, General &
Administrative Expenses |
$1,249.13
|
$8.53 M
|
$2.47 M
|
$2,350.32
|
$1,230.48
|
| Other Expenses |
$0.00 |
-$819,062.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$1,249.13 |
$12.46 M |
$9.59 M |
$2,607.59 |
$1,269.45 |
| Cost And Expenses |
$1,356.23 |
$12.46 M |
$9.59 M |
$2,607.59 |
$1,269.45 |
| Interest Income |
$202.80 |
$2,114.00 |
$160.00 |
$149.30 |
$1.56 |
| Interest Expense |
$0.00 |
$47,958.00 |
$11,471.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$54.73
|
$786,484.00
|
$176,649.00
|
$39.27
|
$8.37
|
| EBITDA |
-$1,356.23
|
-$12.33 M
|
-$8.02 M
|
-$2,350.32
|
-$1,230.48
|
| EBITDA Ratio |
-0 |
-19.55 |
-16.82 |
0 |
0 |
| Operating Income Ratio
|
-0
|
-19.5
|
-17.16
|
0
|
0
|
| Total Other
Income/Expenses Net |
$96.97
|
-$44.14
|
$855,021.00
|
-$107.97
|
-$37.41
|
| Income Before Tax |
-$1,259.26 |
-$13.16 M |
-$8.21 M |
-$2,458.29 |
-$1,267.88 |
| Income Before Tax Ratio
|
-0
|
-21.66
|
-15.54
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$74,000.00 |
$82,067.00 |
$0.00 |
$0.00 |
| Net Income |
-$1,259.26 |
-$13.09 M |
-$8.29 M |
-$2,458.29 |
-$1,267.88 |
| Net Income Ratio |
-0 |
-21.54 |
-15.7 |
0 |
0 |
| EPS |
0 |
-0.74 |
-0.48 |
-0.0004 |
-0.0003 |
| EPS Diluted |
0 |
-0.74 |
-0.48 |
-0.0004 |
-0.0003 |
| Weighted Average Shares
Out |
$29.54 M
|
$17.71 M
|
$17.16 M
|
$6.72 M
|
$3.64 M
|
| Weighted Average Shares
Out Diluted |
$29.54 M
|
$17.71 M
|
$17.16 M
|
$6.72 M
|
$3.64 M
|
| Link |
|
|
|
|
|
